# Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis

> **NCT00523341** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 4550 (actual)

## Conditions studied

- Osteopenia
- Osteoporosis

## Interventions

- **BIOLOGICAL:** Denosumab

## Key facts

- **NCT ID:** NCT00523341
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08-07
- **Primary completion:** 2015-07-19
- **Final completion:** 2015-07-19
- **Target enrollment:** 4550 (ACTUAL)
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523341, "Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00523341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*